NL8101273A - Natriumzout van n-carboxycefadroxyl. - Google Patents
Natriumzout van n-carboxycefadroxyl. Download PDFInfo
- Publication number
- NL8101273A NL8101273A NL8101273A NL8101273A NL8101273A NL 8101273 A NL8101273 A NL 8101273A NL 8101273 A NL8101273 A NL 8101273A NL 8101273 A NL8101273 A NL 8101273A NL 8101273 A NL8101273 A NL 8101273A
- Authority
- NL
- Netherlands
- Prior art keywords
- carboxycephadroxyl
- carboxycefadroxyl
- disodium salt
- cefadroxyl
- sodium salt
- Prior art date
Links
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960004841 cefadroxil Drugs 0.000 description 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2109680 | 1980-04-01 | ||
| IT21096/80A IT1141268B (it) | 1980-04-01 | 1980-04-01 | Sale disodico dell'n-carbossi cefadroxil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8101273A true NL8101273A (nl) | 1981-11-02 |
Family
ID=11176673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8101273A NL8101273A (nl) | 1980-04-01 | 1981-03-16 | Natriumzout van n-carboxycefadroxyl. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4380630A (OSRAM) |
| JP (1) | JPS56152489A (OSRAM) |
| CA (1) | CA1146541A (OSRAM) |
| CH (1) | CH646179A5 (OSRAM) |
| DE (1) | DE3112169A1 (OSRAM) |
| FR (1) | FR2479227A1 (OSRAM) |
| GB (1) | GB2073191A (OSRAM) |
| IL (1) | IL62375A (OSRAM) |
| IT (1) | IT1141268B (OSRAM) |
| NL (1) | NL8101273A (OSRAM) |
| YU (1) | YU84581A (OSRAM) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3489750A (en) * | 1967-09-05 | 1970-01-13 | Bristol Myers Co | 7-amino-cephalosporanic and decephalosporanic acid derivatives |
| BE786924A (fr) * | 1971-07-28 | 1973-01-29 | Squibb & Sons Inc | Antibiotiques, leur preparation et leurs utilisations therapeutiques |
| US4016158A (en) * | 1971-12-31 | 1977-04-05 | Roussel-Uclaf | Cephalosporin derivatives |
| US3985741A (en) * | 1972-09-15 | 1976-10-12 | Bristol-Myers Company | Production of p-hydroxycephalexin |
-
1980
- 1980-04-01 IT IT21096/80A patent/IT1141268B/it active
-
1981
- 1981-03-04 US US06/240,311 patent/US4380630A/en not_active Expired - Lifetime
- 1981-03-10 CA CA000372704A patent/CA1146541A/en not_active Expired
- 1981-03-13 CH CH173281A patent/CH646179A5/it not_active IP Right Cessation
- 1981-03-16 NL NL8101273A patent/NL8101273A/nl not_active Application Discontinuation
- 1981-03-16 IL IL62375A patent/IL62375A/xx unknown
- 1981-03-25 FR FR8106001A patent/FR2479227A1/fr active Granted
- 1981-03-27 JP JP4421581A patent/JPS56152489A/ja active Pending
- 1981-03-27 DE DE19813112169 patent/DE3112169A1/de not_active Ceased
- 1981-03-31 GB GB8109980A patent/GB2073191A/en not_active Withdrawn
- 1981-03-31 YU YU00845/81A patent/YU84581A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2479227A1 (fr) | 1981-10-02 |
| IL62375A (en) | 1983-11-30 |
| CH646179A5 (it) | 1984-11-15 |
| FR2479227B1 (OSRAM) | 1984-02-17 |
| GB2073191A (en) | 1981-10-14 |
| IT8021096A0 (it) | 1980-04-01 |
| DE3112169A1 (de) | 1982-01-14 |
| CA1146541A (en) | 1983-05-17 |
| YU84581A (en) | 1983-10-31 |
| US4380630A (en) | 1983-04-19 |
| JPS56152489A (en) | 1981-11-26 |
| IL62375A0 (en) | 1981-05-20 |
| IT1141268B (it) | 1986-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Deutsch et al. | Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity | |
| HU187068B (en) | Process for preparing crystallic benzenesulphonates of sulfamicilline | |
| SE505258C2 (sv) | Nya dihydrokloridhydrat av 7-(]0a]-(2aminotiazol-4-yl)-]0a]- (Z)-metoxiiminoacetamido)-3-((1-metylpyrrolidino)-metyl)-3- cefem-4-karboxylsyra i kristallin form | |
| DK163514B (da) | Fremgangsmaade til fremstilling af en krystallinsk form af natriumsaltet af et oximderivat af 7-aminothiazolylacetamidocephalosporansyre | |
| FI66388B (fi) | Foerfarande foer framstaellning av 7-(d-alfa-amino-alfa-(p-hydroxifenyl)acetamido)-3-(1,2,3-triazol-5-yltiometyl)-3-cefem-4-karboxylsyra-1,2-propylenglykolat | |
| FR2470134A1 (fr) | Nouveaux antibiotiques, leur preparation et leur utilisation | |
| RU2161619C2 (ru) | Кристаллические соли присоединения кислот цефема, способ их получения, содержащее их лекарственное средство | |
| SU847922A3 (ru) | Способ получени - - -( -окси- -метил-НиКОТиНАМидО)- -( -ОКСифЕНил)АцЕТАМидО - -( -МЕТилТЕТРАзОл- -ил)ТиОМЕТил- -цЕфЕМ- -КАРбОНОВОй КиСлОТы | |
| NL8101273A (nl) | Natriumzout van n-carboxycefadroxyl. | |
| JPH0317840B2 (OSRAM) | ||
| FR2519988A1 (fr) | Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent | |
| US4751220A (en) | Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid | |
| HU181961B (en) | Process for producing new oxime derivatives of 3-thiadiazolythio-methyl-7-aminothiazolylacetamido-ceph-3-eme-4-carboxylic acids | |
| FI67856C (fi) | Foerfarande foer framstaellning av ett antibakteriellt silversalt av fosfanilsyra | |
| EP0261990B1 (en) | Crystalline cephem carboxylic acid addition salt | |
| CZ242094A3 (en) | Process for preparing pure oxytetracycline and intermediate for the preparation thereof | |
| GB1382494A (en) | Acylaminocephalosporanic acids and process for their manufacture | |
| US4810702A (en) | Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient | |
| PT91499B (pt) | Processo para a preparacao de derivados de mitomicina tendo reduzida toxicidade relativamente a medula ossea | |
| KR920004821B1 (ko) | 세포니시드모노나트륨염 | |
| KR840002143B1 (ko) | N-카복시 세파드록실 디나트륨염의 제조방법 | |
| US4094979A (en) | Orally active cephalosporins | |
| US4327105A (en) | Amino-penicillin derivative, and therapeutic composition containing the same | |
| KR101142582B1 (ko) | β-락타마제 효소에 저항성을 갖는 세팔로스포린 에스테르화합물 및 이의 염 | |
| US4035381A (en) | Antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |